Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 46.31
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Syschem India Ltd. engages in the manufacture of bulk drug, intermediates, and specialty chemicals. Its products include amoxicillin tri hydrate, ampicillin tri hydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, oxacillin, and cephalexin. The company was founded on December 31, 1993 and is headquartered in Chandigarh, India.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued
Data is available to registered users only
Buy
Sell